These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8628328)

  • 1. Inhibition of covalent DNA binding and mutagenicity of benzo[a]pyrene by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl) carbamoyl]acetate (YH439), a novel hepatoprotective agent.
    Surh YJ; Shlyankevich M; Lee JW; Yoo JK
    Mutat Res; 1996 Apr; 367(4):219-24. PubMed ID: 8628328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of isopropyl-2-(1,3-dithietane-2-ylidene)-2- [N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439) on benzo[a]pyrene-induced skin carcinogenesis and micronucleated reticulocyte formation in mice.
    Surh YJ; Kim SG; Liem A; Lee JW; Miller JA
    Mutat Res; 1999 Jan; 423(1-2):149-53. PubMed ID: 10029692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vinyl carbamate-induced hepatotoxicity, mutagenicity, and tumorigenicity by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2- yl)carbamoyl]acetate (YH439).
    Kim SG; Surh YJ; Sohn Y; Yoo JK; Lee JW; Liem A; Miller JA
    Carcinogenesis; 1998 Apr; 19(4):687-90. PubMed ID: 9600356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen.
    Tachino N; Guo D; Dashwood WM; Yamane S; Larsen R; Dashwood R
    Mutat Res; 1994 Jul; 308(2):191-203. PubMed ID: 7518046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of hemin, chlorophyllin and related pyrrole pigments on the mutagenicity of benzo[a]pyrene and its metabolites.
    Arimoto S; Kan-yama K; Rai H; Hayatsu H
    Mutat Res; 1995 Dec; 345(3-4):127-35. PubMed ID: 8552134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.
    Vance RE; Teel RW; Strother A
    Cancer Lett; 1990 Apr; 50(2):149-56. PubMed ID: 2109652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tannic acid on rat liver S9 mediated mutagenesis, metabolism and DNA binding of benzo[a]pyrene.
    Vance RE; Teel RW
    Cancer Lett; 1989 Sep; 47(1-2):37-44. PubMed ID: 2517593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse.
    Sticha KR; Staretz ME; Wang M; Liang H; Kenney PM; Hecht SS
    Carcinogenesis; 2000 Sep; 21(9):1711-9. PubMed ID: 10964103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of rat hepatic cytochrome P450 2E1 expression by isopropyl 2-(1,3-dithioetane-2-ylidene)-2-[N-(4-methyl-thiazol-2-yl)carbamoyl] acetate (YH439), an experimental hepatoprotectant: protective role against hepatic injury.
    Choi EY; Kim SG; Lee JW; Yoo JK; Shin JK; Kim ND
    Biochem Pharmacol; 1996 Oct; 52(8):1219-25. PubMed ID: 8937429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite.
    Conney AH; Chang RL; Jerina DM; Wei SJ
    Drug Metab Rev; 1994; 26(1-2):125-63. PubMed ID: 8082562
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents.
    Smith WA; Gupta RC
    Carcinogenesis; 1996 Jun; 17(6):1285-90. PubMed ID: 8681444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Todralazine influence upon the mutagenicity of some direct- and indirect-acting mutagens.
    Gasiorowski K; Szyba K; Urban J
    Mutat Res; 1994 Jul; 324(3):133-7. PubMed ID: 7517512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive activity of chlorophyllin against mouse skin carcinogenesis by benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide.
    Park KK; Surh YJ
    Cancer Lett; 1996 Apr; 102(1-2):143-9. PubMed ID: 8603362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time-dependent increase in the binding of benzo[a]pyrene to DNA through (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide in primary rat hepatocyte cultures results from induction of cytochrome P450IA1 by benzo[a]pyrene treatment.
    Eberhart J; Coffing SL; Anderson JN; Marcus C; Kalogeris TJ; Baird WM; Park SS; Gelboin HV
    Carcinogenesis; 1992 Feb; 13(2):297-301. PubMed ID: 1740021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis.
    Sharma N; Trikha P; Athar M; Raisuddin S
    Drug Chem Toxicol; 2000 Aug; 23(3):477-84. PubMed ID: 10959548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanisms of antimutagens by various teas as judged by their effects on mutagenesis by 2-amino-3-methylimidazo[4,5-f]quinoline and benzo[a]pyrene.
    Chen HY; Yen GC
    Mutat Res; 1997 Sep; 393(1-2):115-22. PubMed ID: 9357568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo [alpha] pyrene-induced genotoxicity and carcinogenicity.
    Azuine MA; Kayal JJ; Bhide SV
    J Cancer Res Clin Oncol; 1992; 118(6):447-52. PubMed ID: 1618892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.